ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

FATE Fate Therapeutics Inc

4.22
0.16 (3.94%)
取引時間後
最終更新日: 05:37:10
15分遅延
名称 銘柄コード 市場 種別
Fate Therapeutics Inc FATE NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.16 3.94% 4.22 05:37:10
始値 安値 高値 終値 前日終値
4.08 4.01 4.26 4.22 4.06
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0621:00GLOBEFate Therapeutics to Webcast Conference Call Reporting First..
2024/5/0405:30GLOBEFate Therapeutics Announces Presentation of FT522..
2024/4/2305:30GLOBEFate Therapeutics Announces Presentation of FT819..
2024/4/0321:00GLOBEFate Therapeutics to Present at 23rd Annual Needham Virtual..
2024/4/0305:01GLOBEFate Therapeutics Reports New Employee Inducement Award..
2024/3/1921:44GLOBEFate Therapeutics Announces Pricing of $100 Million..
2024/3/0606:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0606:01GLOBEFate Therapeutics Reports New Employee Inducement Award..
2024/3/0503:29EDGAR2Form 144 - Report of proposed sale of securities
2024/3/0122:00GLOBEFate Therapeutics to Present at Upcoming March Investor..
2024/2/2706:10EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/2706:03EDGAR2Form 8-K - Current report
2024/2/2706:01GLOBEFate Therapeutics Reports Fourth Quarter and Full Year 2023..
2024/2/1522:00GLOBEFate Therapeutics to Webcast Conference Call Reporting..
2024/2/1308:06EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/2/0306:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0306:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0306:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0306:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0306:01GLOBEFate Therapeutics Reports New Employee Inducement Awards..
2024/1/3106:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/3003:44EDGAR2Form 144 - Report of proposed sale of securities
2024/1/2606:19EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/1/1106:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1106:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1106:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1106:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1006:39EDGAR2Form 144 - Report of proposed sale of securities
2024/1/1006:36EDGAR2Form 144 - Report of proposed sale of securities
2024/1/1006:36EDGAR2Form 144 - Report of proposed sale of securities
2024/1/1006:35EDGAR2Form 144 - Report of proposed sale of securities
2024/1/0822:00GLOBEFate Therapeutics Announces Initiation of Phase 1 Clinical..
2024/1/0406:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0302:17EDGAR2Form 144 - Report of proposed sale of securities
2023/12/2006:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1901:40EDGAR2Form 144 - Report of proposed sale of securities
2023/12/1407:00GLOBEFate Therapeutics Reports New Employee Inducement Grants..
2023/11/2814:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/11/1406:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1001:57EDGAR2Form 144 - Report of proposed sale of securities
2023/11/0907:10EDGAR2Form 8-K - Current report
2023/11/0906:44EDGAR2Form S-3 - Registration statement under Securities Act of..
2023/11/0906:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0906:03EDGAR2Form 8-K - Current report
2023/11/0906:01GLOBEFate Therapeutics Reports Third Quarter 2023 Financial..
2023/10/2521:00GLOBEFate Therapeutics to Webcast Conference Call Reporting Third..
2023/9/0206:29EDGAR2Form 8-K - Current report
2023/8/3121:00GLOBEFate Therapeutics to Present at Upcoming September Investor..
2023/8/2205:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/1904:58EDGAR2Form 144 - Report of proposed sale of securities

最近閲覧した銘柄

Delayed Upgrade Clock